With an in-depth day on research and innovation at the service of health, the Salvatore Maugeri Foundation once again confirms its commitment even in such a delicate moment for global health. The appointment takes on even greater value as it falls on the ‘Researcher’s Day’, with all the Maugeri institutes connected in streaming.
The meeting, hosted in the Auditorium of Irccs Maugeri Pavia, saw the presence as a guest Rino Rappuoli, scientific director and head of Research and Development of GlaxoSmithKline Vaccines. To moderate the debate the journalist Fabio Mazzeo who introduced the interventions of the scientific director Walter Ricciardi and the CEO Maugeri, Mario Melazzini, who from the stage wanted to launch a special thanks: “A big thank you to those who allow all this in everyday life, that is to say all our researchers. I want to highlight their great motivation and the great enthusiasm they have despite the workload, because more than 80% of those who do research in our 19 institutes, of which 9 are recognized by the Ministry of Health, he also does clinical assistance “.
“Ics Maugeri, of which Fondazione Maugeri is the majority shareholder – added Melazzini – is a huge reality that combines research and assistance in a unique combination that allows in everyday life to guarantee the answers that citizens seek in a context that is sometimes extremely difficult . Ics Maugeri is also an integral part of the academic system. Many of our facilities and laboratories are run by university staff and this is the great strength always desired by Professor Salvatore Maugeri and whoever replaced him “.